News

The company currently manufactures and markets the oral capsule in China under the Cease Enuresis oral capsule brand, which was approved by China’s State Food and Drug Administration

Prior to joining Enzo Clinical Labs, Dr Krenitsky, who is replacing Shahram Rabbani, was CEO of Bioserve Biotechnologies. Prior to Bioserve, he was CEO of Parkway Clinical Laboratories.

Mr Bancino will be responsible for managing the company’s global corporate offices and future global expansion efforts. After 15 years with one of the largest global companies in

According to BioImagene, Virtuoso is a role-based system that enables pathologists, histo-technologists, lab administrators and clinicians to improve the efficiency and quality of the anatomical pathology workflow. It

Biophan Technologies, a developer of next-generation medical technology, has received a new patent from the US Patent and Trademark Office that covers important operational aspects of the Myotech

The aggregate purchase price is $33 million, subject to certain adjustments. At MannKind’s option, up to $30 million worth of the company’s common stock may be issued to

Mr Contamine was previously senior executive vice president, deputy general manager and CFO of Veolia Environment. Mr Contamine is a graduate of Ecole Polytechnique (X), and ENSAE, the

The application for the drug was submitted by Ranbaxy from the Ohm Laboratories manufacturing facility, located in North Brunswick, New Jersey, US. The office of generic drugs, FDA,

According to the company, Acanya gel is the only FDA-approved fixed combination antibiotic and benzoyl peroxide (BPO) medication for once-daily treatment of both non-inflammatory and inflammatory lesions of